A photo of Parinda Mehta.

Member, Division of Bone Marrow Transplantation and Immune Deficiency

Professor, UC Department of Pediatrics

513-636-4913

513-803-1969

Board Certified

About Me

Academic Affiliation

Professor, UC Department of Pediatrics

Divisions

Cancer and Blood Diseases, Bone Marrow Transplantation BMT, Fanconi Anemia, Leukemia

My Locations

My Education

BA: Graduated from Parle College, Mumbai, India, 1988.

MD: G.S. Medical College and K.E.M Hospital, Mumbai, India, 1993.

Residency: Upstate Medical University (UMU) - State University of New York (SUNY), Syracuse, NY, 2002.

Fellowship: Cincinnati Children's Hospital Medical Center, Cincinnati, OH, 2005.

Certification: Board Certification, Pediatrics, 2002; Board Certification, Pediatric Hematology Oncology, License, State of Ohio.

My Publications

Selected Publication

Busulfan Pharmacokinetics and Precision Dosing: Are Patients with Fanconi Anemia Different?. Mehta, PA; Emoto, C; Fukuda, T; Seyboth, B; Teusink-Cross, A; Davies, SM; Wilhelm, J; Fuller, K; Vinks, AA; Boulad, F. Biology of Blood and Marrow Transplantation. 2019; 25:2416-2421.

Unique Challenges of Hematopoietic Cell Transplantation in Adolescent and Young Adults with Hematologic Malignancies. Mehta, PA; Rotz, SJ; Majhail, NS. Biology of Blood and Marrow Transplantation. 2018; 24:e11-e19.

Disease burden and conditioning regimens in ASCT1221, a randomized phase II trial in children with juvenile myelomonocytic leukemia: A Children's Oncology Group study. Dvorak, CC; Satwani, P; Stieglitz, E; Cairo, MS; Dang, H; Pei, Q; Gao, Y; Wall, D; Mazor, T; Olshen, AB; et al. Pediatric Blood and Cancer. 2018; 65:e27034-e27034.

Micafungin antifungal prophylaxis in children undergoing HSCT: can we give higher doses, less frequently? A pharmacokinetic study. Chandra, S; Fukuda, T; Mizuno, K; Davies, SM; Teusink-Cross, A; Tarin, R; Marsh, RA; Vinks, AA; Mehta, PA. Journal of Antimicrobial Chemotherapy. 2018; 73:1651-1658.

Subsequent neoplasms and late mortality in children undergoing allogeneic transplantation for nonmalignant diseases. Kahn, JM; Brazauskas, R; Tecca, HR; Bo-Subait, S; Buchbinder, D; Battiwala, M; Flowers, ME D; Savani, BN; Phelan, R; Broglie, L; et al. Blood Advances. 2020; 4:2084-2094.

Population pharmacokinetic modelling of busulfan and the influence of body composition in paediatric Fanconi anaemia patients. van Hoogdalem, MW; Emoto, C; Fukuda, T; Mizuno, T; Mehta, PA; Vinks, AA. British Journal of Clinical Pharmacology. 2020; 86:933-943.

Association of clinical severity with FANCB variant type in Fanconi anemia. Jung, M; Ramanagoudr-Bhojappa, R; van Twest, S; Rosti, RO; Murphy, V; Tan, W; Donovan, FX; Lach, FP; Kimble, DC; Jiang, CS; et al. Blood. 2020; 135:1588-1602.

Chromosome fragility in the buccal epithelium in patients with Fanconi anemia. Jose Ramirez, M; Minguillon, J; Loveless, S; Lake, K; Carrasco, E; Stjepanovic, N; Balmana, J; Catala, A; Mehta, PA; Surralles, J. Cancer Letters. 2020; 472:1-7.

Impact of T Cell Dose on Outcome of T Cell-Replete HLA-Matched Allogeneic Peripheral Blood Stem Cell Transplantation. Saad, A; Lamb, L; Wang, T; Hemmer, MT; Spellman, S; Couriel, D; Alousi, A; Pidala, J; Abdel-Azim, H; Agrawall, V; et al. Biology of Blood and Marrow Transplantation. 2019; 25:1875-1883.

Outcomes after Second Hematopoietic Cell Transplantation in Children and Young Adults with Relapsed Acute Leukemia. Lund, TC; Ahn, KW; Tecca, HR; Hilgers, MV; Abdel-Azim, H; Abrahams, A; Angel Diaz, M; Badawy, SM; Broglie, L; Brown, V; et al. Biology of Blood and Marrow Transplantation. 2019; 25:301-306.